Dizal Pharmaceutical Co., Ltd (Ticker: 688192 ) is a commercial stage biopharmaceutical company. At Dizal we aspire to discover and develop differentiated therapeutics for the treatment of cancer and immunological diseases. Building on our extensive expertise in translational science and molecular design, we have established an internationally competitive portfolio of five clinical-stage assets with two leading assets in global pivotal studies and one already approved.
Company Details
- Employees
- 112
- Founded
- -
- Address
- No 199 Liang Road, Shanghai,shanghai 201203,china
- Phone
- +86-21-61097800
- in****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- dizalpharma.com
- Keywords
- oncology and immunology.
- HQ
- Shanghai, Shanghai
Dizal Pharmaceutical Questions
Dizal Pharmaceutical's helpline number is +86-21-61097800
Dizal Pharmaceutical's website is dizalpharma.com
Dizal Pharmaceutical's LinkedIn profile is https://cn.linkedin.com/company/dizal-pharma
Dizal Pharmaceutical has
112 employees.
View email and phone details for 112
employees at Dizal Pharmaceutical.
Dizal Pharmaceutical's industry is
Biotechnology Research
Dizal Pharmaceutical's top competitors are
Iteos Therapeutics,
迪哲(江苏)医药股份有限公司,
Beigene,
Novartis,
Orphalan,
Sanofi,
Pfizer,
Harbour Biomed,
Innocare Pharma,
Astrazeneca.
Dizal Pharmaceutical's support email address is info@dizalpharma.com
Dizal Pharmaceutical's categories are Biotechnology Research
Dizal Pharmaceutical's founding year is 2017
